CVR number 39589699
Industry 32.5000 Manufacture of medical and dental instruments and supplies

Proteseeksperten ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.9% 2.0% 1.8% 2.0% 1.9%  
Credit score (0-100)  72 69 70 68 69  
Credit rating  A A A A A  
Credit limit (kDKK)  0.6 0.5 1.7 0.4 0.8  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Gross profit  2,235 2,689 3,126 2,972 3,120  
EBITDA  1,098 1,319 1,521 1,377 1,375  
EBIT  1,010 1,192 1,394 1,307 1,339  
Pre-tax profit (PTP)  992.7 1,162.8 1,356.9 1,271.8 1,319.2  
Net earnings  772.5 905.9 1,053.9 989.3 1,026.1  
Pre-tax profit without non-rec. items  993 1,163 1,357 1,272 1,319  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Tangible assets total  114 134 38.5 0.0 137  
Shareholders equity total  823 1,228 1,282 1,272 1,298  
Interest-bearing liabilities  148 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,798 2,293 2,476 2,302 2,272  
Net Debt  -1,082 -1,607 -1,894 -1,769 -663  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,235 2,689 3,126 2,972 3,120  
Gross profit growth  0.0% 20.3% 16.3% -4.9% 5.0%  
Employees  0 0 0 0 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,798 2,293 2,476 2,302 2,272  
Balance sheet change%  0.0% 27.5% 8.0% -7.0% -1.3%  
Added value  1,098.1 1,318.9 1,521.4 1,434.6 1,374.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  309 -139 -254 -140 70  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  45.2% 44.3% 44.6% 44.0% 42.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  56.1% 58.3% 58.5% 54.7% 58.6%  
ROI %  104.0% 108.4% 111.1% 102.4% 103.7%  
ROE %  93.9% 88.3% 84.0% 77.5% 79.9%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  45.7% 53.6% 51.8% 55.2% 57.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -98.5% -121.9% -124.5% -128.4% -48.3%  
Gearing %  18.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  22.7% 39.3% 0.0% 0.0% 0.0%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  2.0 2.2 2.2 2.5 2.5  
Current Ratio  2.1 2.4 2.3 2.6 2.6  
Cash and cash equivalent  1,230.2 1,607.1 1,894.0 1,769.4 663.5  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  719.9 1,091.6 1,265.4 1,288.0 1,205.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 687  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 687  
EBIT / employee  0 0 0 0 670  
Net earnings / employee  0 0 0 0 513